Print

Engineered Small Pox May Kill Liver Cancer, University of California, San Diego (UCSD) Study  
4/10/2013 7:32:12 AM

As part of a multicenter clinical trial, researchers at University of California, San Diego School of Medicine are evaluating Pexa-Vec (JX-594) to slow the progression of hepatocellular carcinoma (HCC) or liver cancer. Pexa-Vec is a genetically engineered virus that is used in the smallpox vaccine.
//-->